Provided herein are methods for evaluating tumor cell spheroids in a three-dimensional microfluidic device by determining changes in the relative levels of live cells and dead cells in aliquots cultured under different conditions. Methods described herein allow ex vivo recapitulation of the tumor microenvironment such that the in vivo effectiveness of a test compound in treating tumor tissue may be predicted.

Disclosed are methods and systems and computer program products for determining DPB1 expression without the need for rs9277534 (3′ UTR) sequence data. Such methods are useful in assessing HLA sequencing submitted to or already in donor databases for matches that will reduce the risk of hematopoietic transplant rejection (i.e., graft vs. host disease).

Disclosed are methods and systems and computer program products for determining DPB1 expression without the need for rs9277534 (3′ UTR) sequence data. Such methods are useful in assessing HLA sequencing submitted to or already in donor databases for matches that will reduce the risk of hematopoietic transplant rejection (i.e., graft vs. host disease).

The present disclosure provides methods for processing extracellular vesicles in which the extracellular vesicles are not purified, prior to contacting with a fluorescent staining dye or an antibody. By utilizing a centrifugal filter, excess staining dye or antibody can be readily removed prior to analysis of one or more characteristics of the extracellular vesicles. The methods provide rapid and simple processing and analysis, while maintaining a high concentration of extracellular vesicles.

The present disclosure provides methods for processing extracellular vesicles in which the extracellular vesicles are not purified, prior to contacting with a fluorescent staining dye or an antibody. By utilizing a centrifugal filter, excess staining dye or antibody can be readily removed prior to analysis of one or more characteristics of the extracellular vesicles. The methods provide rapid and simple processing and analysis, while maintaining a high concentration of extracellular vesicles.

A method of determining a percentage of cell-types in a saliva specimen includes the steps of obtaining genomic DNA from the saliva specimen, observing cytosine methylation at specific CG loci in the genomic DNA of the saliva specimen, comparing the observed methylation with the methylation observed in genomic DNA collected from a reference group of saliva specimens and correlating the CG loci methylation observed in the genomic DNA of the saliva specimen with the methylation observed in the genomic DNA of the reference group of saliva specimens to determine the percentage of cell-types in the saliva specimen.

A method of determining a percentage of cell-types in a saliva specimen includes the steps of obtaining genomic DNA from the saliva specimen, observing cytosine methylation at specific CG loci in the genomic DNA of the saliva specimen, comparing the observed methylation with the methylation observed in genomic DNA collected from a reference group of saliva specimens and correlating the CG loci methylation observed in the genomic DNA of the saliva specimen with the methylation observed in the genomic DNA of the reference group of saliva specimens to determine the percentage of cell-types in the saliva specimen.

The disclosure relates to a method of culturing and analyzing at least one cell in a microchamber configured to allow for optical inspection of the at least one cell, wherein liquid is extracted from the microchamber for analysis, characterized in that the analysis returns information about particles secreted from the at least one cell and that this information can be correlated to the individual cell and/or cell population. The disclosure further relates to a device for use in the method and a system and a computer program for performing one or more of the steps of the method.

The disclosure relates to a method of culturing and analyzing at least one cell in a microchamber configured to allow for optical inspection of the at least one cell, wherein liquid is extracted from the microchamber for analysis, characterized in that the analysis returns information about particles secreted from the at least one cell and that this information can be correlated to the individual cell and/or cell population. The disclosure further relates to a device for use in the method and a system and a computer program for performing one or more of the steps of the method.

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.